Lineage Cell Therapeutics, Inc.
LCTX· NYSE
LCTXLineage Cell Therapeutics, Inc.
Quarterly figures for Lineage Cell Therapeutics, Inc., with source filings when available.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Lineage Cell Therapeutics, Inc. has filed its 10-Q within 37 to 45 days of period end across its last 8 quarters. The 10-K runs 64 to 73 days.
Lineage Cell Therapeutics, Inc. · CIK 876343 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 6, 2026 · after-hours | Aug 6, 2026 | 37 d | 10-Q | $1.07M | −61.3% | -$0.03 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 12, 2026 · after-hours |
| May 12, 2026 |
| 42 d |
| 10-Q |
| $1.73M |
| +14.8% |
| -$0.03 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Mar 5, 2026 · after-hours | Mar 5, 2026 | 64 d | 10-K | $6.61M | +130.4% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 6, 2025 · after-hours | Nov 6, 2025 | 37 d | 10-Q | $3.68M | −2.6% | -$0.13 | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | $2.77M | +96.4% | -$0.13 | |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 · after-hours | May 13, 2025 | 43 d | 10-Q | $1.50M | +4.0% | -$0.02 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 10, 2025 · after-hours | Mar 10, 2025 | 69 d | 10-K | $2.87M | +37.4% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 · after-hours | Nov 14, 2024 | 45 d | 10-Q | $3.78M | +203.3% | -$0.02 | |
| Q2 2024 | Jun 30, 2024 | Aug 8, 2024 · after-hours | Aug 8, 2024 | 39 d | 10-Q | $1.41M | −56.3% | -$0.03 | |
| Q1 2024 | Mar 31, 2024 | May 9, 2024 · after-hours | May 9, 2024 | 39 d | 10-Q | $1.44M | −39.5% | -$0.04 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023 | Dec 31, 2023 | Mar 7, 2024 · after-hours | Mar 7, 2024 | 67 d | 10-K | $2.09M | +9.0% | -$0.03 | |
| Q3 2023 | Sep 30, 2023 | Nov 9, 2023 · after-hours | Nov 9, 2023 | 40 d | 10-Q | $1.25M | −58.4% | -$0.04 | |
| Q2 2023 | Jun 30, 2023 | Aug 10, 2023 · after-hours | Aug 10, 2023 | 41 d | 10-Q | $3.23M | −29.2% | -$0.03 | |
| Q1 2023 | Mar 31, 2023 | May 11, 2023 · after-hours | May 11, 2023 | 41 d | 10-Q | $2.39M | −54.4% | -$0.03 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022 | Dec 31, 2022 | Mar 9, 2023 · after-hours | Mar 9, 2023 | 68 d | 10-K | $1.92M | +64.0% | -$0.03 | |
| Q3 2022 | Sep 30, 2022 | Nov 10, 2022 · after-hours | Nov 10, 2022 | 41 d | 10-Q | $3.00M | +32.1% | -$0.04 | |
| Q2 2022 | Jun 30, 2022 | Aug 11, 2022 · after-hours | Aug 11, 2022 | 42 d | 10-Q | $4.55M | +789.3% | -$0.04 | |
| Q1 2022 | Mar 31, 2022 | May 12, 2022 · after-hours | May 12, 2022 | 42 d | 10-Q | $5.24M | +1,239.4% | -$0.04 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021 | Dec 31, 2021 | Mar 10, 2022 · after-hours | Mar 10, 2022 | 69 d | 10-K | $1.17M | +229.0% | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 10, 2021 | 41 d | 10-Q | $2.27M | +297.5% | -$0.05 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 12, 2021 | 43 d | 10-Q | $512.00K | +32.6% | -$0.03 | |
| Q1 2021 | Mar 31, 2021 | — | May 13, 2021 | 43 d | 10-Q | $391.00K | −23.9% | -$0.01 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | — | Mar 11, 2021 | 70 d | 10-K | $355.00K | −71.4% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 4, 2020 | 35 d | 10-Q | $571.00K | +0.7% | -$0.05 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 6, 2020 | 37 d | 10-Q | $386.00K | −50.4% | -$0.04 | |
| Q1 2020 | Mar 31, 2020 | — | May 7, 2020 | 37 d | 10-Q | $514.00K | −44.6% | -$0.06 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 12, 2020 | 72 d | 10-K | $1.24M | +63.7% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 12, 2019 | 43 d | 10-Q | $567.00K | −42.3% | -$0.11 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 8, 2019 | 39 d | 10-Q | $779.00K | −69.4% | -$0.20 | |
| Q1 2019 | Mar 31, 2019 | — | May 9, 2019 | 39 d | 10-Q | $928.00K | +32.4% | $0.30 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | Mar 14, 2019 | 73 d | 10-K | $758.00K | −19.8% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 8, 2018 | 39 d | 10-Q | $982.00K | −41.8% | $0.53 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 2, 2018 | 33 d | 10-Q | $2.55M | +568.5% | -$0.03 | |
| Q1 2018 | Mar 31, 2018 | — | May 10, 2018 | 40 d | 10-Q | $701.00K | +110.5% | -$0.50 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Mar 15, 2018 | 74 d | 10-K | $945.00K | −14.3% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 9, 2017 | 40 d | 10-Q | $1.69M | +17.1% | $0.12 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 9, 2017 | 40 d | 10-Q | $381.00K | −67.5% | -$0.11 | |
| Q1 2017 | Mar 31, 2017 | — | May 10, 2017 | 40 d | 10-Q | $333.00K | −82.0% | $0.46 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Mar 16, 2017 | 75 d | 10-K | $1.10M | −15.5% | -$0.05 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 4, 2016 | 35 d | 10-Q | $1.44M | −23.1% | $0.30 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 9, 2016 | 40 d | 10-Q | $1.17M | −33.0% | $0.26 | |
| Q1 2016 | Mar 31, 2016 | — | May 10, 2016 | 40 d | 10-Q | $1.85M | +84.8% | -$0.19 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Mar 15, 2016 | 75 d | 10-K | $1.31M | −21.6% | -$0.16 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 9, 2015 | 40 d | 10-Q | $1.87M | +95.2% | -$0.18 | |
| Q2 2015 | Jun 30, 2015 | — | Aug 10, 2015 | 41 d | 10-Q | $1.75M | +104.6% | -$0.12 | |
| Q1 2015 | Mar 31, 2015 | — | May 8, 2015 | 38 d | 10-Q | $1.00M | +7.0% | -$0.13 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | Mar 11, 2015 | 70 d | 10-K | $1.67M | −0.3% | -$0.14 | |
| Q3 2014 | Sep 30, 2014 | — | Nov 7, 2014 | 38 d | 10-Q | $960.00K | +89.2% | -$0.12 | |
| Q2 2014 | Jun 30, 2014 | — | Aug 11, 2014 | 42 d | 10-Q | $855.00K | −17.4% | -$0.16 | |
| Q1 2014 | Mar 31, 2014 | — | May 12, 2014 | 42 d | 10-Q | $935.00K | +116.6% | -$0.14 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | Mar 17, 2014 | 76 d | 10-K | $1.67M | +56.7% | -$0.35 | |
| Q3 2013 | Sep 30, 2013 | — | Nov 12, 2013 | 43 d | 10-Q | $507.38K | −49.4% | -$0.16 | |
| Q2 2013 | Jun 30, 2013 | — | Aug 9, 2013 | 40 d | 10-Q | $1.04M | +0.2% | -$0.14 | |
| Q1 2013 | Mar 31, 2013 | — | May 10, 2013 | 40 d | 10-Q | $431.72K | −31.7% | -$0.15 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | Mar 18, 2013 | 77 d | 10-K | $1.07M | −34.7% | -$0.12 | |
| Q3 2012 | Sep 30, 2012 | — | Nov 9, 2012 | 40 d | 10-Q | $1.00M | −13.6% | -$0.10 | |
| Q2 2012 | Jun 30, 2012 | — | Aug 9, 2012 | 40 d | 10-Q | $1.03M | +32.5% | -$0.11 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $631.95K | −23.4% | -$0.10 | |
| FY 2011 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2011 | Dec 31, 2011 | — | — | — | — | $1.63M | — | -$0.10 | |
| Q3 2011 | Sep 30, 2011 | — | — | — | — | $1.16M | +42.5% | -$0.08 | |
| Q2 2011 | Jun 30, 2011 | — | Aug 9, 2011 | 40 d | 10-Q | $780.37K | +14.7% | -$0.09 | |
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $824.63K | — | -$0.07 | |
| FY 2010 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2010derived | Dec 31, 2010 | — | — | — | — | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | — | — | — | $815.28K | — | -$0.11 | |
| Q2 2010 | Jun 30, 2010 | — | — | — | — | $680.28K | — | -$0.06 | |
